Published in Ocular Surface

Intelligently Implementing Rescue Therapies

This is editorially independent content supported by advertising from Sun Ophthalmics
5 min read

Join Damon Dierker, OD, FAAO, and Richard Maharaj, OD, FAAO, to discuss which rescue therapies to recommend when patients have dry eye flares.

In this episode of Dry Eye Fireside Chat, Damon Dierker, OD, FAAO, and Richard Maharaj, OD, FAAO, discuss rescue therapies for dry eye disease, including how to identify, educate, and manage patients in need of these interventions.

Rescue in sight for dry eye patients

"My team and I really rely on a multimodal approach, incorporating evidence-based protocols and advanced diagnostics. However, there can be bumps in the road and points where we as a team really need to steer the ship,” noted Dr. Maharaj.
As managing partner of optometry services at Prism Eye Institute in Ontario, Canada, a collaborative ophthalmology-optometry group that focuses on complex treatment-resistant cases, Dr. Maharaj and his team see well over 5,000 cases each year.
Nevertheless, although they develop routine long-term ocular management plans for each patient, there can be unexpected setbacks. This is where rescue therapies come in—interventions used to address acute issues unreceptive to a patient’s standard management regimen.

To learn how primary care optometrists can catch ocular surface disease during comprehensive exams, check out The Simple Dry Eye Workup for Primary Care Optometrists!

Identifying when to intervene

What signs signify that a patient might be experiencing—or about to experience—a flare? Dr. Maharaj also evaluates contact lens intolerance.
”Sometimes a patient will tell me that they stopped wearing their contact lenses for a couple of weeks, and although it may be said in passing, their tone and body language can indicate displeasure at losing the quality of day-to-day living and freedom, and could be a potential reaction to a flare.”
Visual instability is another sign he takes note of. “Around winter, we’ll usually have some patients that complain of blurry vision, attributing this to the longer nights and poorer weather—however, vision stability shouldn’t be an issue if the tear film is stable,” Dr. Maharaj says. “It’s another potential symptom of an ongoing or upcoming flare.”

No shame, all gain with dry eye flares

“It’s been my experience that patients can feel like they’ve failed when they have a dry eye flare," he added. Therefore, he works to dispel any negative connotations around rescue therapy by explaining that it is an opportunity to press reset on whatever issue they’re facing.
According to Dr. Maharaj, “An analogy I often use is dental care: you can brush your teeth and floss every day and still get a cavity—when that happens, we need to first deal with the cavity before anything else, but it’s not the end of the line.
Framing it like this helps patients to understand that rescue doesn’t mean failure; it’s actually a necessary part of regaining control and homeostasis.”

Educate early on dry eye

Dr. Maharaj reminds us that we don’t need to wait until rescue therapies are needed to begin education. “I aim to do much of the heavy lifting at a patient’s initial visit by letting them know that I expect that they may experience an average of four to six flares in a given year.”
Having this knowledge can mean that patients are less likely to feel that their core therapies are failing when they experience flares. However, if doubt does occur, Dr. Maharaj reminds patients of where they started prior to treatment and how effective the current strategies have been thus far.
He added, “Photography is also a great education tool, which is why it’s important to always have it on hand to show patients where they were, where they are, and where they could be.”

Amniotic membranes for short-term relief

“DEWS III was recently rereleased; it advocates for addressing the subtype first1—this requires us to identify the core etiology, which in turn can really help to drive rescue therapy," explained Dr. Maharaj.
To this end, he treats instances of flares as one-off occurrences and typically doesn’t alter a patient’s long-term management plan following rescue therapy implementation.
“As a general rule, I keep patients either on a 3 or 6-month interval for their maintenance sessions, and then we handle flares as and when they show up.” However, in the short term, Dr. Maharaj often employs amniotic membranes as a rescue treatment modality.
“I’ve found amniotic membranes to be a really nice fire blanket; putting it on the cornea quickly calms any inflammation," he explained. “It can serve as a literal reset of the cornea.”

In closing

Flares can serve as opportunities for education and encouragement. Dr. Maharaj stated, “When a flare does occur, alongside reminding them that it’s not the end of the line but a rescue, I also like to use it as an opportunity to encourage patients to be proactive and preventative, not reactive.
It’s a chance to ensure patients are staying attuned to their maintenance schedule, which can be really key in reducing the number of these flares that do occur.”
  1. Stapleton F, Argüeso P, Asbell P, et al. TFOS DEWS III Digest Report. Am J Ophthalmol. 2025;S0002-9394(25)00276-4. doi: 10.1016/j.ajo.2025.05.040. Epub ahead of print. PMID: 40472874
Damon Dierker, OD, FAAO
About Damon Dierker, OD, FAAO

Dr. Dierker is Director of Optometric Services at Eye Surgeons of Indiana, an adjunct faculty member at the Indiana University School of Optometry, and Immediate Past President of the Indiana Optometric Association. Dr. Dierker is the Co-Founder and Program Chair of Eyes On Dry Eye, the largest event for eyecare professionals in the industry. He has made significant contributions to raising awareness of dry eye and ocular surface disease in the eyecare community, including the development of Dry Eye Boot Camp and other content resources across dozens of publications.

Damon Dierker, OD, FAAO
Richard L. Maharaj, OD, FAAO
About Richard L. Maharaj, OD, FAAO

Dr. Richard Maharaj is the current medical director for eyeLABS Center for Ocular Surface Disease, a leading specialty eye care and research facility with multiple locations in Southern Ontario. He obtained his Doctor of Optometry from the University of Waterloo School of Optometry and is an active Fellow of the American Academy of Optometry.

Richard L. Maharaj, OD, FAAO
How would you rate the quality of this content?
Eyes On Eyecare Site Sponsors
Astellas Logo